5-fluorouracil treatment in GI cancers tied to risk of myocardial infarction: Study
Denmark: A new study has suggested that patients receiving 5-fluorouracil (5-FU) for gastrointestinal cancers are at a higher 6- and 12-month risk for myocardial infarction (MI), however, the absolute...
Source: medicaldialogues.in